SOPHIA BIOSCIENCE
Sophia Bioscience develops new pharmaceutical treatments for early and metastatic cancers. It aims to increase the effectiveness of established drugs while lowering their required dosage and minimizing side effects. Sophia Bioscience also works to improve the drug development process, shortening the time to develop and significantly lowering associated costs. The company is currently focused on treating prostate cancer. The first drug candidate Sophia has put forward uses an independent anti-tumor chemotype, HDACi, and exploits prostate tumor androgen receptors (AR) for a more selective delivery than existing drugs. By exploiting these receptors, the drug resolves the issue of insufficient accumulation in the tumor and localizes the effects of the HDACi.
SOPHIA BIOSCIENCE
Industry:
Biotechnology Health Care Life Science Therapeutics
Status:
Active
Total Funding:
59.17 K USD
Investors List
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Sophia Bioscience
More informations about "Sophia Bioscience"
Sophia Bioscience - Crunchbase Company Profile & Funding
Sophia Bioscience develops new pharmaceutical treatments for early and metastatic cancers. It aims to increase the effectiveness of established drugs while lowering their required dosage …See details»
Sophia Bioscience - Funding, Financials, Valuation & Investors
Sophia Bioscience develops new pharmaceutical treatments for early and metastatic cancers. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ...See details»
Leadership - The Sophia Consulting Firm
Sophia Ononye, PhD MPH MBA is a Nigerian American, Yale-trained Scientist, and Entrepreneur with over 15 years of cross-functional experience in the biopharmaceutical industry across drug discovery, medical affairs, strategic …See details»
Sophia Bioscience Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sophia Bioscience Inc of Marietta, GA. Get the latest business insights from Dun & Bradstreet.See details»
SOPHiA GENETICS
At SOPHiA GENETICS we established our 7 Virtues to clarify how our principles show up each day through action. At the centre of our Virtues is our Mantra, We Care, which provides a …See details»
Sophia Bioscience - Tech Stack, Apps, Patents & Trademarks
Organization. Sophia Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by …See details»
Sophia Bioscience - Overview, News & Similar companies
Sophia Bioscience is a company that operates in the Biotechnology industry. It employs 6-10 people and has $1M-$5M of revenue. Is this data correct? Popular Searches Sophia …See details»
SOPHIA BIOSCIENCE, INC. - Drug pipelines, Patents, Clinical trials ...
Explore SOPHIA BIOSCIENCE, INC. with its drug pipeline, therapeutic area, technology platform, .See details»
SOPHIA BIOSCIENCE INC - VentureRadar
Similar Companies: Tethers Unlimited, Inc. USA Privately Held Tethers Unlimited, Inc. (TUI) is an American private aerospace company headquartered near Seattle, Washington, which …See details»
SOPHiA GENETICS - Where others see data we see …
Retain ownership of your data. SOPHiA DDM™: A universal healthcare analytics platform. Powered by AI and machine learning (ML), our global cloud-based platform provides a safe, secure, and instantly accessible environment to …See details»
Georgia Research Alliance - GRA
Sophia Bioscience develops new pharmaceutical treatments for early and metastatic cancers. The company aims to increase the effectiveness of established drugs while lowering their required …See details»
David Gaul - Interim CEO - Sophia Bioscience | LinkedIn
Interim CEO at Sophia Bioscience · Experience: Sophia Bioscience · Education: Georgia Institute of Technology · Location: Atlanta · 274 connections on LinkedIn. View David Gaul’s profile on ...See details»
Home - SOFIE
Trilantic North America Completes Strategic Growth Investment in SOFIE Biosciences Patrick Phelps 2024-06-03T20:17:45+00:00 [18F]FAPI-74 serving as complementary diagnostic in …See details»
Sophia Bioscience - Crunchbase
Sophia Bioscience develops new pharmaceutical treatments for early and metastatic cancers.See details»
Partnering - SOPHiA GENETICS
“SOPHiA GENETICS is a leader in precision medicine,” said Keiji Kojima, Executive Vice President and Executive Officer, and General Manager of Smart Life Business Management …See details»
Team - SOFIE
Our team works alongside our Pharma and Academic partners to revolutionize clinical diagnostics and therapeutics to better understand and treat the biology of disease.See details»
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand …
Sep 10, 2024 The companies commit to bring cutting-edge liquid biopsy testing to 20 institutions globally over the next 12 months. BOSTON and ROLLE, Switzerland, September 10, 2024– …See details»
Research programme: prostate cancer therapeutics - Sophia …
Sophia Bioscience is developing therapeutics for the treatment of prostate cancer. Development is at the preclinical stage in the US. Research programme: prostate cancer therapeutics - Sophia …See details»
SOPHiA GENETICS Transforms Global Healthcare with Data
Oct 16, 2024 SOPHiA GENETICS is a team that loves to connect concepts with tangible results and real-world impact. Ushering in the next breakthrough in healthcare technology is no easy …See details»
Sophia Bioscience - Updates, News, Events, Signals & Triggers
Edit Recent News & Activity Section. Funding Round • Feb 6, 2017. Sophia Bioscience raised $59,170 / Grant from Georgia Research Alliance raised $59,170 / Grant from Georgia …See details»